AIM
IONS icon

Acrospire Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Acrospire Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-700
Closed -$36K – 705
2017
Q2 		$36K Sell
700
-1,100
-61% -$51.2K 0.03% 1153
2017
Q1 		$72K Sell
1,800
-1,200
-40% -$53.9K 0.06% 590
2016
Q4 		$143K Buy
3,000
+2,200
+275% +$87.1K 0.06% 657
2016
Q3 		$29K Sell
800
-400
-33% -$12.5K 0.02% 1356
2016
Q2 		$28K Buy
1,200
+500
+71% +$16.1K 0.02% 1417
2016
Q1 		$28K Buy
+700
New +$28.4K 0.02% 1356

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Acrospire Investment Management's IONS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2017, closing a stake of 700 shares — an estimated $36K sold.

Acrospire Investment Management first reported a position in IONS in Q1 2016 and held it in 6 quarters. The position peaked at $143K in Q4 2016. 301 funds tracked by Wall St. Rank hold IONS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Ionis Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 700 Ionis Pharmaceuticals shares in Q3 2017, an estimated $36K.
  • Acrospire Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Ionis Pharmaceuticals position peaked at $143K in Q4 2016.
  • 301 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.